Results for tag: "Diabetic Complication Drug"

The Diabetic Complication Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. These drugs are used to treat the complications of diabetes, such as diabetic neuropathy, diabetic retinopathy, and diabetic nephropathy. These drugs are used to reduce the risk of long-term complications, such as blindness, kidney failure, and nerve damage. They can also help to reduce the risk of cardiovascular disease and stroke. Commonly used drugs include insulin, sulfonylureas, thiazolidinediones, and GLP-1 agonists. Some of the major companies in the Diabetic Complication Drug market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the development, manufacturing, and marketing of drugs for the treatment of diabetes and its complications. Show Less Read more